Chia-Yen Chen Selected Research

Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)

12/2010

Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chia-Yen Chen Research Topics

Disease

5	Neoplasms (Cancer) 01/2015 - 08/2005
4	Schizophrenia (Dementia Praecox) 01/2024 - 01/2020
3	Mental Disorders (Mental Disorder) 01/2024 - 01/2021
2	Multiple Sclerosis 01/2023 - 01/2021
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 09/2011
2	Substance-Related Disorders (Drug Abuse) 12/2020 - 01/2020
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020 - 10/2019
2	Fever (Fevers) 11/2013 - 01/2013
2	Laminopathies 09/2012 - 04/2012
2	Hepatocellular Carcinoma (Hepatoma) 03/2012 - 02/2009
2	Overactive Urinary Bladder (Overactive Bladder) 03/2011 - 12/2010
2	Severe Acute Respiratory Syndrome 08/2007 - 11/2006
2	Infections 11/2006 - 02/2006
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2024
1	COVID-19 10/2023
1	Genetic Risk Score 01/2022
1	Neurodevelopmental Disorders 01/2022
1	Obesity 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Opioid-Related Disorders (Opiate Addiction) 12/2020
1	Anhedonia 08/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Osteoporosis 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Myocardial Infarction 01/2020
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2020
1	Parkinson Disease (Parkinson's Disease) 10/2019
1	Disease Progression 01/2016
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2016
1	Hydronephrosis 01/2015
1	Ureteral Obstruction 01/2015
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 11/2013
1	Aneurysm (Aneurysms) 11/2013
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2012
1	Breast Neoplasms (Breast Cancer) 09/2011
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 12/2010
1	Urinary Incontinence 12/2010
1	Lower Urinary Tract Symptoms 12/2009
1	Liver Neoplasms (Liver Cancer) 02/2009
1	Hyperpigmentation 08/2005
1	Genomic Instability 08/2005
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2005
1	Vascular Diseases (Vascular Disease) 08/2005
1	Wounds and Injuries (Trauma) 08/2003

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 10/2023 - 11/2006
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2005
2	Nicotine FDA Link 12/2020 - 01/2020
2	Intravenous Immunoglobulins (IVIG)FDA Link 11/2013 - 01/2013
2	Glycine N-Methyltransferase (Glycine Sarcosine N-Methyltransferase)IBA 03/2012 - 02/2009
2	Nerve Growth Factor (NGF)IBA 03/2011 - 12/2010
2	EnzymesIBA 11/2006 - 02/2006
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2024
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2024
1	Vitamin D3 24-HydroxylaseIBA 01/2023
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Sp4 Transcription FactorIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Nootropic Agents (Nootropics)IBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	hydroxide ionIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 08/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 08/2020
1	ManganeseIBA 01/2020
1	MetalsIBA 01/2020
1	romosozumabIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	GlycosyltransferasesIBA 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 10/2019
1	Sorting NexinsIBA 11/2013
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 12/2012
1	Genetic Markers (Genetic Marker)IBA 09/2011
1	Type A Botulinum Toxins (Botox)FDA Link 12/2009
1	NucleotidesIBA 08/2007
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2006
1	Intercellular Adhesion Molecule-3IBA 11/2006
1	VaccinesIBA 11/2006
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 11/2006
1	Neutralizing AntibodiesIBA 02/2006
1	Oxidants (Oxidizing Agents)IBA 08/2005
1	AntioxidantsIBA 08/2005
1	ArsenicIBA 08/2005
1	monomethylarsonic acid (MSMA)IBA 08/2005
1	Drinking WaterIBA 08/2005
1	bismuth subgallateIBA 08/2003
1	Ointments (Pastes)IBA 08/2003
1	isoborneol (borneol)IBA 08/2003
1	Petrolatum (Vaseline)FDA Link 08/2003

Therapy/Procedure

1	Art Therapy 01/2016
1	Stents 01/2015
1	Drug Therapy (Chemotherapy) 12/2012